NO952205L - Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter - Google Patents
Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenterInfo
- Publication number
- NO952205L NO952205L NO952205A NO952205A NO952205L NO 952205 L NO952205 L NO 952205L NO 952205 A NO952205 A NO 952205A NO 952205 A NO952205 A NO 952205A NO 952205 L NO952205 L NO 952205L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- medicaments
- heterocyclic carbamates
- carbamates
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Denne oppfinnelse vedrører heterocykliske karbamater med formelen (I) (R2) (I) fremgangsmåter for deres fremstilling og medikamenter inne- holdende disse.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4333761A DE4333761A1 (de) | 1993-10-04 | 1993-10-04 | Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel |
| PCT/EP1994/003280 WO1995009842A1 (en) | 1993-10-04 | 1994-10-04 | Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952205D0 NO952205D0 (no) | 1995-06-02 |
| NO952205L true NO952205L (no) | 1995-06-02 |
Family
ID=6499349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952205A NO952205L (no) | 1993-10-04 | 1995-06-02 | Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5679677A (no) |
| EP (1) | EP0649839A1 (no) |
| JP (1) | JPH08504216A (no) |
| AU (1) | AU684314B2 (no) |
| CA (1) | CA2148361A1 (no) |
| DE (2) | DE4333761A1 (no) |
| FI (1) | FI952324A7 (no) |
| NO (1) | NO952205L (no) |
| WO (1) | WO1995009842A1 (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7261742B2 (en) | 2005-10-13 | 2007-08-28 | S.C. Johnson & Son, Inc. | Method of deodorizing a textile |
| US7407922B2 (en) * | 2005-10-13 | 2008-08-05 | S.C. Johnson & Son, Inc. | Deodorizing compositions |
| AU2007282678B2 (en) * | 2006-08-08 | 2012-09-27 | Aska Pharmaceutical Co., Ltd. | Quinazoline derivative |
| US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| ES2475193T3 (es) | 2007-01-22 | 2014-07-10 | Gtx, Inc. | Agentes de unión al receptor nuclear |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| JP2010520875A (ja) | 2007-03-09 | 2010-06-17 | レノビス, インコーポレイテッド | P2x7調節因子としてのビシクロヘテロアリール化合物およびその使用 |
| AU2011270701B2 (en) | 2010-06-24 | 2015-05-14 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| US9868728B2 (en) | 2010-10-29 | 2018-01-16 | Emory University | Quinazoline derivatives, compositions, and uses related thereto |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| MX2021012208A (es) | 2013-10-04 | 2023-01-19 | Infinity Pharmaceuticals Inc | Compuestos heterocíclicos y usos de los mismos. |
| NZ724368A (en) | 2014-03-19 | 2023-07-28 | Infinity Pharmaceuticals Inc | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| EP4585268A3 (en) | 2015-09-14 | 2025-10-15 | Twelve Therapeutics, Inc. | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
| US10759806B2 (en) | 2016-03-17 | 2020-09-01 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors |
| WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE36226B1 (en) * | 1935-11-11 | 1976-09-15 | Shimamoto Takio | Phthalazone derivatives |
| FR1460552A (fr) * | 1965-04-22 | 1966-03-04 | Agripat Sa | Additifs à des nourritures pour animaux |
| NL6702189A (no) * | 1967-02-14 | 1968-08-15 | ||
| DE1807685A1 (de) * | 1968-11-08 | 1970-08-06 | Chinoin Gyogyszer Es Vegyeszet | Neue Chinazolon-Derivate und Verfahren zur Herstellung derselben |
| CH540266A (de) * | 1968-12-04 | 1973-08-15 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von Chinazolon-Derivaten |
| JPS5418270B2 (no) * | 1971-12-06 | 1979-07-06 | ||
| AR205004A1 (es) * | 1973-10-30 | 1976-03-31 | Ishikawa M | Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona |
| US4293553A (en) * | 1978-08-11 | 1981-10-06 | Masayuki Ishikawa | 1-Phthalazone derivatives, and use thereof |
| GB2127805A (en) * | 1982-09-13 | 1984-04-18 | Showa Denko Kk | Phthalazones |
| JPS5976069A (ja) * | 1982-10-25 | 1984-04-28 | Showa Denko Kk | フタラゾン誘導体 |
| US4769367A (en) * | 1984-04-24 | 1988-09-06 | Glaxo Group Limited | Heterocyclic amino compounds |
-
1993
- 1993-10-04 DE DE4333761A patent/DE4333761A1/de not_active Withdrawn
- 1993-10-04 DE DE4345266A patent/DE4345266C2/de not_active Expired - Fee Related
-
1994
- 1994-10-04 EP EP94115598A patent/EP0649839A1/en not_active Withdrawn
- 1994-10-04 JP JP7510611A patent/JPH08504216A/ja active Pending
- 1994-10-04 CA CA002148361A patent/CA2148361A1/en not_active Abandoned
- 1994-10-04 US US08/446,867 patent/US5679677A/en not_active Expired - Fee Related
- 1994-10-04 FI FI952324A patent/FI952324A7/fi unknown
- 1994-10-04 AU AU77845/94A patent/AU684314B2/en not_active Ceased
- 1994-10-04 WO PCT/EP1994/003280 patent/WO1995009842A1/en not_active Ceased
-
1995
- 1995-06-02 NO NO952205A patent/NO952205L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI952324L (fi) | 1995-05-12 |
| DE4333761A1 (de) | 1995-04-06 |
| JPH08504216A (ja) | 1996-05-07 |
| FI952324A0 (fi) | 1995-05-12 |
| EP0649839A1 (en) | 1995-04-26 |
| WO1995009842A1 (en) | 1995-04-13 |
| DE4345266C2 (de) | 1996-12-19 |
| AU684314B2 (en) | 1997-12-11 |
| US5679677A (en) | 1997-10-21 |
| CA2148361A1 (en) | 1995-04-13 |
| DE4345266A1 (de) | 1995-06-29 |
| NO952205D0 (no) | 1995-06-02 |
| FI952324A7 (fi) | 1995-05-12 |
| AU7784594A (en) | 1995-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO952205L (no) | Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter | |
| NO305074B1 (no) | Aminosyrederivater, medikamenter inneholdende disse forbindelser og anvendelser derav | |
| EP0528858A4 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| DK104292D0 (da) | Heterocycliske forbindelser og fremgangsmaade til deres fremstilling | |
| NO932620L (no) | Amindiol-proteaseinhibitorer | |
| DK15589D0 (da) | Kemiske forbindelser | |
| UA35574C2 (uk) | Похідні заміщеної гетероциклом фенілциклогексанкарбонової кислоти, суміші їх ізомерів або окремі ізомери та їх солі | |
| DK0417698T3 (da) | Aminosyrederivater med reninhæmmende egenskaber, fremgangsmåde til deres fremstilling, midler med indhold deraf og deres anvendelse | |
| NO840048L (no) | Disubstituerte prolinderivater, fremgangsmaate til deres fremstilling og deres anvendelse | |
| NO933524D0 (no) | Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav | |
| DK270789A (da) | Hirudin-derivater, deres fremstilling og anvendelse | |
| AU6319480A (en) | 2-hydroxyalkyl-3,4,5-trihydroxypiperidines | |
| ATE48001T1 (de) | Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate. | |
| MY105538A (en) | Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them. | |
| DK0658585T3 (da) | Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og midler indeholdende disse som antik | |
| DK0998471T3 (da) | Heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse | |
| ES2022342B3 (es) | Hidrazinas n-(opcinalmente sustituidas)-n'-sustituidas-n, n'-disustituidas, insecticidas. | |
| DK613687A (da) | Kondenserede heterocycliske tetrahydroaminoquinolinoler og beslaegtede forbindelser, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
| SI0736009T1 (en) | N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs | |
| ATE69220T1 (de) | Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen. | |
| ATE189894T1 (de) | Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel | |
| DK0527079T3 (da) | N-(isoquinolin-5-yl)-sulfonyl-azacykloalkaner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| NO992316L (no) | Benzensulfonamidderivater og legemidler inneholdende disse | |
| ES8602676A1 (es) | Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina. | |
| ATE154027T1 (de) | Glycosylamide von 2-aminoacylamino-2-desoxy- zuckern |